Concepedia

Julia A. Beaver

JA

Statistics

Publications

101

Citations

8.7K

H-Index

53

Active since

1993

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Sidney Kimmel Comprehensive Cancer Center

Center for Devices and Radiological Health

Johns Hopkins University

Julia A. Beaver is an author at United States Food and Drug Administration specializing in medicine, oncology, and pharmacology.

Publications per year

1993–2024

101

Publications

101

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors

Leigh Marcus, Lola A. Fashoyin‐Aje, Martha Donoghue et al. · Clinical Cancer Research · 2021 · 568 citations · Full text

Medicine, Oncology, Pharmacology +17

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement

Edward S. Kim, Suanna S. Bruinooge, Samantha Roberts et al. · Journal of Clinical Oncology · 2017 · 482 citations

Medicine, Child Health, Clinical Trial Regulation +16

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan et al. · Clinical Cancer Research · 2014 · 396 citations

Medicine, Molecular Biology, Oncology +14

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

V. Ellen Maher, Laura L. Fernandes, Chana Weinstock et al. · Journal of Clinical Oncology · 2019 · 346 citations

Medicine, Oncology, Pharmacology +17

FDA Approval Summary: Sotorasib for <i>KRAS G12C</i> -Mutated Metastatic NSCLC

Erica C. Nakajima, Nicole Drezner, Xiaoxue Li et al. · Clinical Cancer Research · 2021 · 305 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 101